K-numberK253354
Device nameMinvitro Embryo Transfer Catheters (ETCA23175, ETCA23175-C, ETCB20175, ETCB20175-C, ETCB20175-ET, ETCB20175-ET-C)
ApplicantGuangzhou Hehong Biotech Co., Ltd.
Product codeMQF
Device classClass II
Decision dateFeb 12, 2026
DecisionSubstantially Equivalent
Regulation884.6110
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Minvitro Embryo Transfer Catheters are sterile, single-use medical devices designed to place in vitro fertilized (IVF) embryos into the uterine cavity during assisted reproduction procedures. The system consists of a transfer catheter loaded with embryos, a guide catheter to direct insertion, and optional stylet components, with variations including straight echogenic and pre-curved guide options.

Technological characteristics

The subject device differs from the predicate in design features (e.g., positioner and bulb-tip design in ETCB20175 series), materials (PE, TPU, PEBAX, silicone vs. polyurethane and fluoric resin), dimensions (transfer catheter OD 0.95 mm vs. 1.55 mm), sterilization method (electron beam vs. ethylene oxide), and shelf-life (2 years vs. 3 years). Despite these differences, both devices share the same fundamental intended use and safety profile.

Test standards cited

ISO 11137-1:2006 and ISO 11137-2:2013 (sterilization validation); ASTM D4169-22 (transportation simulation); ASTM F1886/F1886M-16, F88/F88M-23, F1929-23 (packaging integrity); ISO 10993-5:2009, ISO 10993-10:2021, ISO 10993-23:2021 (biocompatibility); USP <85> (endotoxin); FDA 2021 Mouse Embryo Assay guidance; ASTM F1980-21 (accelerated aging).

Substantial equivalence argument

Although the subject device and predicate device exhibit different technological characteristics in design, materials, dimensions, sterilization method, and shelf-life, they share the same intended use (embryo transfer into the uterine cavity) and regulatory classification (Class II, 21 CFR 884.6110). Comprehensive non-clinical testing demonstrated equivalent safety and performance, including biocompatibility, endotoxin levels (<20 EU/device), mouse embryo assay results (≥80% blastocyst development), and bench performance testing before and after accelerated aging, supporting a determination of substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →